Skip to main content

Salvage Prostatectomy for USF

Salvage prostatectomy can form part of selected bladder-sparing repair of urosymphyseal fistula (USF) when a diseased prostate remains in situ. It is not the default operation for all USF: the fistula can arise from a bladder neck or urethra after prior radical prostatectomy, and many irradiated patients require cystectomy with urinary diversion and pubic-bone debridement.[4][6]

When the bladder is salvageable, urinary reconstruction may use bladder-neck closure with a continent catheterizable channel, with augmentation when needed, or a carefully selected vesicourethral anastomosis (VUA). The small historical series establishing feasibility of closure, augmentation and a channel treated mainly recurrent cancer after radiation, rather than USF. They do not establish this as the preferred USF reconstruction or demonstrate superiority over VUA.[1][2][3]

See USF / PPF bladder-sparing approaches for the broader decision, male fistula atlas for diversion alternatives, and bladder reconstruction for augmentation and channel technique.

Selection and Planning​

The first decision is whether preservation can achieve both infection control and a useful, safely emptied reservoir. Relevant factors include the extent of radiation damage, necrosis, fistulation and osteomyelitis; bladder capacity and compliance; outlet and sphincter function; prior cancer treatment; renal function; bowel suitability; and the patient's goals and ability to manage the reconstruction.[4][8][17]

  • Prostate in situ: required for prostatectomy, but not for every bladder-sparing operation. Prior prostatectomy changes the repair anatomy; it does not alone rule out all bladder preservation.
  • Bladder viability and function: severe radiation cystitis, uncontrolled bleeding, destructive necrosis or a reservoir that cannot be made useful may favor cystectomy. Storage symptoms alone do not prove that augmentation is necessary.
  • Emptying after bladder-neck closure: a continent channel requires reliable intermittent catheterization by the patient or a dependable caregiver. Assess dexterity, cognition, access to the proposed stoma and support. Inability to catheterize does not automatically make VUA safe; an incontinent diversion may be more appropriate.
  • Fitness and expectations: explain bowel and urinary complications, possible staged procedures, persistent incontinence, conversion to diversion and the demands of lifelong follow-up. This is major multidisciplinary reconstruction, without a universal operative-time threshold.[1][2][8][17]

Interpreting the USF evidence​

Patel's systematic review included 248 cases from 31 publications. Among the reported postradiation surgical approaches, 184/214 (86%) underwent cystectomy and 30/214 (14%) bladder-sparing treatment. The 14% includes different repairs and is not a salvage-prostatectomy rate or a prospectively validated eligibility estimate. In Bugeja's 16-patient series, 15 underwent surgery: seven had reconstruction using salvage prostatectomy with substitution or augmentation cystoplasty and eight underwent cystectomy. Treatment was selected according to anatomy and tissue condition.[4][6]

Preoperative assessment​

MRI maps the fistula, pubic-bone and soft-tissue involvement; CT can identify collections and assess other pelvic or upper-tract pathology. Endoscopy and contrast studies help define the urinary defect and outlet. The systematic review reported MRI confirmation in 95% of cases; this is not a diagnostic-sensitivity estimate from a controlled accuracy study. Urodynamics may help when bladder function is uncertain and results would change reconstruction.[6][8][17]

Obtain urine cultures, address sepsis and drain relevant collections. Plan intraoperative bone cultures and histology with the surgical and infectious-disease teams: in Andrews' 25-patient series, urine and bone cultures were discordant in 21/22 paired samples. Urine culture alone is therefore an unreliable guide to the final osteomyelitis regimen.[7]

Operative Framework​

These are reconstructive principles, not a single standardized sequence. The dissection, extent of bone resection and urinary endpoint must be planned together; pubectomy and prostate removal need not occur in one fixed order.[4][17]

Source control and prostate removal​

Expose the fistula and involved urinary structures, drain cavities, and remove necrotic tissue and infected bone sufficiently to achieve source control. Preserve healthy structures where possible and obtain deep specimens. Orthopedic, colorectal or plastic-surgery involvement depends on the extent of bone, rectal or soft-tissue disease.[7][17]

When the prostate remains involved, salvage prostatectomy removes the diseased prostatic segment and permits reconstruction above the damaged outlet. Radiation fibrosis can obscure the plane between prostate and rectum, increasing injury risk. Protect the rectum, ureters and usable sphincteric structures; do not assume that a planned outlet closure makes injury to adjacent structures inconsequential.[4][9]

Nerve preservation is determined by viable anatomy, cancer considerations and the need to clear diseased tissue. Erectile recovery is often poor, but it is not universally zero: Stephenson's cancer-salvage series reported some recovery after selected nerve preservation. These cancer outcomes cannot predict erectile function after infected USF reconstruction.[9]

Bladder-neck closure and reservoir reconstruction​

A viable, securely closed bladder outlet can be combined with a continent catheterizable channel. Augmentation is selective, depending on the residual reservoir's capacity, compliance and symptoms; an adequate bladder may not require it. Spahn's heterogeneous 17-patient devastated-outlet series included eight without augmentation and nine with ileocecal augmentation.[8]

Ullrich's five-patient technique used intestinal augmentation of the bladder-neck closure after prostatectomy—four ileocecal patches and one sigmoid segment. It should not be described as a mandatory separate bowel flap simply laid outside an otherwise closed bladder neck. These patients had heterogeneous unsalvageable urethral disease, and the series does not establish a standard USF operation.[5]

For a catheterizable reconstruction, select an appendix-based or reconfigured ileal channel according to available tissue, reach, vascularity and access. The historical salvage series used appendix, Monti and spiral Monti channels; their small samples do not establish a universal order of preference. Site the stoma with the patient before surgery. See principles of continent catheterizable channels for channel construction and long-term management.[1][3][8]

Tissue coverage and drainage​

Vascularized interposition, often omentum, separates the urinary reconstruction from the debrided bone and helps fill pelvic dead space. Choose the flap and pedicle according to reliable perfusion and reach. Plan reservoir and channel drainage, pelvic drains and assessment of healing according to the actual repair; no single catheter size or fixed drainage duration has been validated for every USF reconstruction.[4][17]

Outcomes of Closure, Augmentation and a Channel​

The following are small cancer-salvage cohorts, not a head-to-head USF comparison. The De and Zafirakis reports share the same institution and October 2000–February 2003 recruitment period and may overlap; do not pool them as independent cohorts.[1][2][3]

ReportPopulation and outcomeImportant limitations or harms
Pisters 200013 men with recurrent prostate cancer after radiation; 10/12 survivors were dry between catheterizationsFour serious complications required further surgery, including one death after small-bowel leak and sepsis; one patient required delayed cystectomy
De 200711 patients, mean follow-up 32 months; physician assessment classified 8/11 dryNine answered questionnaires: 4/9 reported no leakage and 7/9 used no absorbent protection—these are different endpoints. Three of 11 required stomal revision
Zafirakis 201012 patients, mean follow-up 61 months; 10/12 dry while catheterizing at reported intervals of 3–8 hoursFour revisions: two for stenosis and two for relocation, not four stenoses. Small selected sample; no randomized comparator

These reports support feasibility and describe the tradeoffs of avoiding a urethral outlet. They do not show that complications stop accumulating after five years or that every patient will be dry. Important late risks include channel stenosis or leakage, catheterization difficulty, stones, bowel-segment metabolic effects and reservoir perforation.[3][5][8]

Variant: Vesicourethral Anastomosis Instead of Bladder-Neck Closure​

VUA aims to retain urethral voiding. It requires viable tissue, an acceptable reservoir and an outlet that can be reconstructed without tension. Retropubic scarring is a reason to reconsider mobilization or the reconstructive endpoint, not a reason to accept a tense anastomosis. The risk of persistent incontinence, stenosis, leakage and recurrent fistulation must be weighed against the feasibility and burden of catheterizable or incontinent diversion.[4][9][17]

What cancer-salvage data can—and cannot—tell us​

A 2025 meta-analysis of salvage prostatectomy for radiorecurrent cancer reported pooled one-year rates of approximately 49.6% any incontinence, 24.6% moderate-to-severe incontinence and 17.8% severe incontinence. Observational open-versus-robotic subgroup differences cannot establish a platform effect. These figures inform discussion of the compromised outlet, but are not USF-specific probabilities or comparative evidence against bladder-neck closure.[10]

Similarly, a matched NSQIP analysis found higher odds after salvage than primary robotic prostatectomy for urinary leak/fistula (OR 3.94, 95% CI 1.85–8.39) and gastrointestinal injury (OR 1.80, 95% CI 1.09–2.98). These are odds ratios in a cancer-surgery dataset, not USF risk ratios; gastrointestinal injury is not synonymous with rectal injury.[11]

The small Ogaya-Pinies study reported anastomotic leakage in 1/15 scaffold-assisted salvage cases versus 16/45 matched salvage controls. This observational study does not establish that a biologic scaffold prevents recurrent USF or should be placed routinely in an infected reconstruction.[16]

Stenosis and subsequent instrumentation​

Radiation and repeated instrumentation can contribute to a compromised outlet. A 2026 primary-prostatectomy cohort reported a five-year combined VUAS/urethral-stricture risk of 7.3% with radiotherapy versus 2.1% without it; 7.3 was a percentage, not a hazard ratio. This was not a cohort undergoing salvage prostatectomy for USF.[14]

Matsushita described 12 pubovesical fistulas after radiation and endoscopic treatment of bladder-neck contracture. This supports caution about further instrumentation in damaged tissue, but not a deterministic numerical sequence from VUA to stenosis to recurrent USF. Recurrent pain, infection or leakage warrants reassessment before further outlet procedures.[15]

Cystectomy Comparison and Follow-up​

No direct trial establishes that salvage prostatectomy with augmentation is safer than cystectomy for USF. In a 31-patient TURNS series of radiation-associated anterior urinary fistulas, 19 had cystectomy and 12 repair; 26/31 reported postoperative pain resolution, with one fistula recurrence. The cohort included fistulas to the pubic symphysis and thigh and treatment was selected, limiting comparisons.[13]

Myers compared 29 patients with prostatic fistula undergoing diversion against 40 with localized radiation injury: major complications occurred in 44.8% versus 20%, and reoperation for pelvic abscess in 37.9% versus 5%. These are fistula-versus-localized-injury groups, not bladder-sparing-versus-cystectomy results.[12]

After reconstruction, verify healing before changing drainage, teach reliable catheterization where required and individualize emptying intervals and mucus irrigation to the reservoir. Monitor renal function, upper tracts, metabolic effects and nutritional consequences according to the reconstruction. Persistent pain, fever, difficult catheterization or leakage requires prompt reassessment. Antimicrobial agent, route and duration should follow deep cultures, source control and infectious-disease advice; a fixed six-to-eight-week intravenous-to-oral sequence is not a USF-specific standard.[3][7][8][17]

References​

1. Pisters LL, English SF, Scott SM, et al. "Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy." J Urol. 2000;163(6):1771–1774. doi:10.1016/s0022-5347(05)67539-8

2. De E, Pisters LL, Pettaway CA, Scott S, Westney OL. "Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months." J Urol. 2007;177(6):2200–2204. doi:10.1016/j.juro.2007.01.151

3. Zafirakis H, De EJ, Pisters LL, Pettaway C, Westney OL. "Long-term outcomes and patient satisfaction of continent catheterizable limb and augmentation cystoplasty simultaneous with salvage prostatectomy." Neurourol Urodyn. 2010;29 Suppl 1:S51–S56. doi:10.1002/nau.20898

4. Bugeja S, Andrich DE, Mundy AR. "Fistulation into the pubic symphysis after treatment of prostate cancer: an important and surgically correctable complication." J Urol. 2016;195(2):391–398. doi:10.1016/j.juro.2015.08.074

5. Ullrich NF, Wessells H. "A technique of bladder neck closure combining prostatectomy and intestinal interposition for unsalvageable urethral disease." J Urol. 2002;167(2 Pt 1):634–636. doi:10.1016/S0022-5347(01)69101-8

6. Patel N, Mehawed G, Dunglison N, et al. "Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework." Urology. 2023;178:1–8. doi:10.1016/j.urology.2023.05.002

7. Andrews JR, Hebert KJ, Boswell TC, et al. "Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment." BJU Int. 2021;128(4):460–467. doi:10.1111/bju.15333

8. Spahn M, Kocot A, Loeser A, Kneitz B, Riedmiller H. "Last resort in devastated bladder outlet: bladder neck closure and continent vesicostomy — long-term results and comparison of different techniques." Urology. 2010;75(5):1185–1192. doi:10.1016/j.urology.2009.11.070

9. Stephenson AJ, Scardino PT, Bianco FJ, et al. "Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy." J Urol. 2004;172(6 Pt 1):2239–2243. doi:10.1097/01.ju.0000140960.63108.39

10. Zhou Y, He X, Yu Q, Zhong Q. "Functional outcomes and complications following salvage radical prostatectomy for post radiotherapy recurrent prostate cancer: a meta-analysis." Medicine (Baltimore). 2025;104(39):e44440. doi:10.1097/MD.0000000000044440

11. Mundra V, Titus RS, Luna E, et al. "Morbidity and mortality of salvage radical prostatectomy for prostate cancer: an analysis of the National Surgical Quality Improvement Program targeted prostatectomy database." Urol Oncol. 2025. doi:10.1016/j.urolonc.2025.07.019

12. Myers JB, Hernandez BS, McCormick B, et al. "Comparison of urinary diversion in patients with prostatic fistula to those with localized radiation injury after radiotherapy for the treatment of prostate cancer." Urology. 2024;183:256–263. doi:10.1016/j.urology.2023.11.006

13. Osterberg EC, Vanni AJ, Gaither TW, et al. "Radiation-induced complex anterior urinary fistulation for prostate cancer: a retrospective multicenter study from the Trauma and Urologic Reconstruction Network of Surgeons (TURNS)." World J Urol. 2017;35(7):1037–1043. doi:10.1007/s00345-016-1983-3

14. Massouh K, Leucht K, Leistritz L, Grimm MO. "Retrospective analysis of vesicourethral-anastomosis stricture / urethral stricture after robotic-assisted laparoscopic radical prostatectomy with and without radiotherapy." Int J Urol. 2026;33(1):e70339. doi:10.1111/iju.70339

15. Matsushita K, Ginsburg L, Mian BM, et al. "Pubovesical fistula: a rare complication after treatment of prostate cancer." Urology. 2012;80(2):446–451. doi:10.1016/j.urology.2012.04.036

16. Ogaya-Pinies G, Kadakia Y, Palayapalayam-Ganapathi H, et al. "Use of scaffolding tissue biografts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduces leak rates and catheter times." Eur Urol. 2018;74(1):92–98. doi:10.1016/j.eururo.2016.10.004

17. Haas C, Feinberg A, Koch GE, Patel HV. "The Diagnosis and Management of Urosymphyseal Fistula with Pubic Osteomyelitis." Curr Urol Rep. 2025;26:62. doi:10.1007/s11934-025-01293-1